GRILLI, Mariagrazia
 Distribuzione geografica
Continente #
EU - Europa 3.177
NA - Nord America 2.618
AS - Asia 736
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.548
Nazione #
US - Stati Uniti d'America 2.609
IE - Irlanda 972
IT - Italia 647
SE - Svezia 516
DE - Germania 412
UA - Ucraina 351
VN - Vietnam 270
CN - Cina 245
FI - Finlandia 182
HK - Hong Kong 122
IN - India 41
GB - Regno Unito 39
FR - Francia 23
IR - Iran 21
BE - Belgio 20
KR - Corea 14
TR - Turchia 14
BR - Brasile 8
CA - Canada 7
EU - Europa 6
NL - Olanda 5
RO - Romania 5
IL - Israele 4
JP - Giappone 4
RU - Federazione Russa 3
AR - Argentina 2
MX - Messico 2
BA - Bosnia-Erzegovina 1
CL - Cile 1
PH - Filippine 1
PT - Portogallo 1
Totale 6.548
Città #
Dublin 972
Jacksonville 648
Dearborn 305
Piemonte 281
Dong Ket 270
Chandler 211
Wilmington 194
Hong Kong 120
Lawrence 118
Princeton 118
Ann Arbor 113
Beijing 109
San Mateo 90
Albano Laziale 70
Ashburn 68
Andover 57
Bremen 40
Milan 33
Houston 32
Philadelphia 28
Woodbridge 28
Boardman 22
Nanjing 22
Brussels 18
Norwalk 18
Kunming 16
Monmouth Junction 15
Helsinki 14
Hefei 13
Leawood 11
Noicattaro 11
Guangzhou 10
Kocaeli 10
Strasbourg 10
Torino 10
Zanjan 10
Fairfield 9
Turin 8
Fuzhou 7
Jinan 7
Toronto 7
Chengdu 6
Des Moines 6
Nanchang 6
Odalengo Grande 6
Rome 6
Seattle 6
Venezia 6
Zhengzhou 6
Ardabil 5
Cattolica 5
Novara 5
Trecate 5
Vercelli 5
Baotou 4
Florence 4
Opera 4
São Paulo 4
Augusta 3
Brescia 3
Chongqing 3
Hebei 3
Henderson 3
Monfalcone 3
Mülheim 3
Nanning 3
Nürnberg 3
San Diego 3
Simi Valley 3
Wuhan 3
Berlin 2
Bologna 2
Campinas 2
Candelo 2
Cassano Magnago 2
Central 2
Como 2
Dallas 2
Dokuz 2
Ercolano 2
Genova 2
La Plata 2
Lainate 2
Laurel 2
Mexico City 2
Orbetello 2
Redwood City 2
Sacramento 2
Segrate 2
Shenyang 2
Tianjin 2
Trasaghis 2
Amsterdam 1
Blaubeuren 1
Bucharest 1
Cambridge 1
Camerino 1
Casale Sul Sile 1
Changsha 1
Chestnut Hill 1
Totale 4.330
Nome #
The noradrenergic component in tapentadol action counteracts μ-opioid receptor-mediated adverse effects on adult neurogenesis 114
Compounds useful for increasing neurogenesis in neural tissue" 99
Salmeterol, a selective and long-lasting β2 adrenergic agonist, promotes adult hippocampal neuroplasticity 94
NF-κB mediated regulation of adult hippocampal neurogenesis: relevance to mood disorders and antidepressant activity 91
Deletion of calcineurin from GFAP-expressing astrocytes impairs excitability of cerebellar and hippocampal neurons through astroglial Na+ /K+ ATPase 88
Proneurogenic Effects of Trazodone in Murine and Human Neural Progenitor Cells 86
Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model 84
Cell autonomous and noncell-autonomous role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells. 81
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death 80
Characterization of [3H]Dopamine uptake sites and [3H]Cocaine recognition sites in primary cultures of mesencephalic neurons during in vitro development 79
Advances in stem cell therapy for amyotrophic lateral sclerosis 78
Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis. 77
Upregulation of mGlu2 receptors via NF-kB p65 acetylation is involved in the proneurogenic and antidepressant effects of acetyl-L-carnitine 76
Tapentadolo: l'innovazione farmacologica per il dolore 75
Interleukin-10 modulates neuronal threshold of vulnerability to ischemic damage 73
α2δ Ligands Act as Positive Modulators of Adult Hippocampal Neurogenesis and Prevent Depression-Like Behavior Induced by Chronic Restraint Stress 73
Salmeterol, a β2 Adrenergic Agonist, Promotes Adult Hippocampal Neurogenesis in a Region-Specific Manner. 72
Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice 72
NF-kB proteins in adult neurogenesis: relevance for learning and memory in physiology and pathology 71
USE OF SELECTED NON-STEROIDAL ANTIINFLAMMATORY COMPOUNDS FOR THE PREVENTION AND THE TREATMENT OF NEURODEGENERATIVE DISEASES 70
Compounds useful for increasing neurogenesis in neural tissue 70
High-Mobility Group Box-1 Protein and β-Amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via Receptor for Advanced Glycation Endproducts/Nuclear Factor-kB axis: Relevance for Alzheimer’s disease. 69
The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells 68
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors 68
Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain. 67
Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies 67
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 66
Not only a bad guy: Potential proneurogenic role of the RAGE/NF-κB axis in Alzheimer’s disease brain 66
INTERLEUKIN-2 GENE-REGULATION IN NONTRANSFORMED CD4+ LYMPHOCYTE-T CLONES 65
Compounds useful for increasing neurogenesis in neural tissue 65
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 65
Acetyl-L-Carnitine promotes adult hippocampal neurogenesis in vitro via NF-kB mediated upregulation of mGlu2 receptors 65
TGF-β2 and TGF-β3 from cultured β-amyloid-treated or 3xTg-AD-derived astrocytes may mediate astrocyte-neuron communication 65
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice 64
Nuclear Factor κB-Dependent Neurite Remodeling Is Mediated by Notch Pathway 64
NF-kappaB and Rel: participants in a multiform transcriptional regulatory system 64
Amyloid Precursor Protein (APP) gene expression is controlled by a NF-κB/rel related protein 63
Opiate analgesics as negative modulators of adult hippocampal neurogenesis: potential implications in clinical practice 63
NF-kappaB subunit regulation in non-transformed CD4+ T lymphocytes 62
Common mechanisms in cell cycle and cell death 62
Treatment with kaempferol: A possible tool to restore neurogenesis in Down syndrome? 62
Studies on an endogenous modulator of voltage-dependent Ca2+ channels in neurons and cardiac myocytes 61
Induction of p53 in the glutamate-induced cell death program 60
L-Acetylcarnitine: a mechanistically distinctive and potentially rapid-acting antidepressant drug. 60
ASTROGLIAL-NF-KB IN LEARNING AND MEMORY AND NEUROGENEIS: TOWARD A BETTER UNDERSTANDING ON SEX-LINKED NEUROPSYCHIATRIC AND NEUROBEHAVIORAL DISORDERS 60
Evidence for the involvement of distinct voltage-sensitive Calcium channels in the release of 3H-Dopamine from primary cultures of mesencephalic neurons 60
Neurogenesis deficits in Down syndrome: testing recovery with GABA alpha 5 negative allosteric modulator, beta 2 adrenergic agonist and IGF-1 in Ts65Dn mice. 60
Molecular mechanisms involved in transport and release of dopamine in primary cultures of mesencephalic neurons 59
Molecular mechanisms of glutamate-induced neurodegeneration 59
ASTROGLIAL NF-kappa B REGULATES HIPPOCAMPAL NEUROGENESIS AND SPATIAL MEMORY IN FEMALE MICE 59
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236 in rodents: a comparison of efficacy and side-effect profiles 59
Beta2 and Alpha2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine 59
Molecular characterization of the neuroprotective activity of salicylates 58
A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties 58
Dopamine Receptor Agonists for Protection and Repair in Parkinson's Disease: An Update 58
ALPHA2-DELTA LIGANDS PROMOTE ADULT NEUROGENESIS IN VITRO VIA NF-kappa B SIGNALING 58
New insights on trazodone effect in promoting neuronal differentiation of adult murine hippocampal neural progenitor cells 58
Endogenous modulator for calcium channel activity 57
A TRANSCRIPTIONAL REPRESSOR OF THE INTERLEUKIN-2 GENE MAY ALSO CONTROL APP GENE-EXPRESSION 57
Alzheimer's disease linking neurodegeneration with neurodevelopment 57
Novel insights into the role of NF-κB p50 in astrocyte-mediated fate specification of adult neural progenitor cells 57
A novel nuclear factor binds to the NF-kappaB motif in the Interleukin-2 enhancer 56
Complex and regional-specific changes in the morphological complexity of GFAP+ astrocytes in middle-aged mice. 56
Nuclear Factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction 55
Neuropathic pain-induced depressive-like behavior is associated with myelin remodeling and impaired neurogenesis 55
Impaired adult neurogenesis associated with short-term memory defects in NF-kappaB p50-deficient mice 54
Adult cellular neuroadaptations induced by adolescent THC exposure in female rats are rescued by enhancing anandamide signaling 53
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of APP695 52
Ecdysone-based system for controlled inducible expression of metabotropic glutamate receptor subtypes 2, 5 and 8 52
A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone 52
NF-kappa B PROTEINS AS POTENTIAL TARGETS FOR PHARMACOLOGICAL MODULATION OF HIPPOCAMPAL NEUROGENESIS 52
Pharmacological rationale for tapentadol therapy: a review of new evidence 52
Tapentadol: an effective option for the treatment of back pain 52
THE P50 MEMBER OF THE NF-kappa B FAMILY REGULATES ADULT NEUROGENESIS IN THE HIPPOCAMPUS AND NOT IN THE OLFACTORY BULB 51
Transcriptional pharmacology of neurodegenerative disorders: novel venue towards neuroprotection against excitotoxicity?” 51
Molecular characterization of the neuroprotective activity of salicylates 51
Early growth response 2 (Egr-2) expression is triggered by NF-κB activation. 51
Melanocortin 4 receptor stimulation improves social deficits in mice through oxytocin pathway 51
Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome 51
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 51
Activation of β2adrenergic receptors promotes adult hippocampal neurogenesis 51
Tumor Necrosis Factor alpha mediates a T cell receptor-independent induction of the gene regulatory factor NF-kappaB in T lymphocytes 50
Contribution of NF-kappaB and p53 in the glutamate-induced apoptosis 50
Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling 50
Adult dorsal root ganglia sensory neurons express the early neuronal fate marker doublecortin 50
Tricyclic thienopyridine–pyrimidones/thienopyrimidine–pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain 50
Astrocyte-Derived Paracrine Signals: Relevance for Neurogenic Niche Regulation and Blood-Brain Barrier Integrity 50
Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway 49
Cortical Structure Alterations and Social Behaviour Impairment in p50-Deficient Mice 49
Calcium signals induced by extracellular application of NAADP in developing neurons and glial cells 49
Dopamine receptor agonists for protection and repair in Parkinson's Disease 47
Members of the NF-kappaB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain 47
Long-lasting induction of notch-2 in the hippocampus of kainate-treated adult mice 47
Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome 47
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas: II, dorsal hippocampus 46
Correction: Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model (Cell Death & Disease, (2019), 10, 1, (24), 10.1038/s41419-018-1264-8) 45
DISTINCT DIFFERENCES BETWEEN TAPENTADOL AND MORPHINE IN AN IN VITRO MODEL OF ADULT NEUROGENESIS 44
Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically 43
Regulation of mouse Neuropeptide Y-Y1 receptor gene transcription: a potential role for Nuclear factor-kappaB/Rel proteins 42
Synthesis and SAR Development of Novel mGluR1 Antagonists for the Treatment of Chronic Pain. 42
Totale 6.123
Categoria #
all - tutte 28.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 12 8
2019/20201.255 37 1 114 22 191 180 285 66 133 80 143 3
2020/20211.226 123 12 120 17 101 38 136 24 133 47 155 320
2021/2022873 116 7 146 76 37 9 57 20 50 41 137 177
2022/20231.972 155 109 142 74 128 147 52 115 944 6 68 32
2023/2024422 43 40 51 17 110 1 116 22 1 21 0 0
Totale 6.837